PubHawk
Pharmacol Res January 2023 PMID 36460279

Cucurbitacin B: A review of its pharmacology, toxicity, and pharmacokinetics.

Shu Dai, Cheng Wang, XingTao Zhao, Cheng Ma, Ke Fu, Yanfang Liu, Cheng Peng, Yunxia Li

Full text PDF Download social card

Mentions

4
Peak: 1 in Mar 2023
across 2 sources since Mar 2023

Extended reach

2,821
potential audience

Total likes

7

Video views

1,068

Mentions per month

Mar 2023 – Nov 2025

Where it's discussed

  • YouTube3 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussions highlight multiple therapeutic activities attributed to Cucurbitacin B, using words like 'potent,' 'anti-inflammatory,' and 'antiviral,' which convey enthusiasm about its potential. However, there is little engagement with the limitations noted in the review, indicating a general positive outlook but limited critical analysis.

AgreementModerate agreement

The discussion reflects a general agreement that Cucurbitacin B has significant pharmacological effects, supported by the mention of multiple beneficial activities.

InterestModerate interest

Participants show moderate interest, focusing on the compound's diverse therapeutic potentials without delving into detailed concerns or limitations.

EngagementNeutral engagement

The posts are somewhat superficial, acknowledging key effects but lacking in-depth analysis or critique of the research findings.

ImpactModerate impact

The emphasis on multiple biological activities suggests the discussions recognize the potential impact of Cucurbitacin B, though there's limited discussion on challenges like toxicity.

Abstract in brief

  • Cucurbitacin B (CuB) is a highly active compound found mainly in plants from the Cucurbitaceae family, with a wide range of pharmacological effects including anti-inflammatory, antioxidant, antiviral, and anticancer activities, operating through multiple signaling pathways.
  • The systematic review of studies from 1986 to 2022 highlights that while CuB has promising therapeutic potential, it also exhibits nonspecific toxicity and low bioavailability, which are challenges for its clinical use.
  • Research also explores CuB derivatives and potential clinical applications, emphasizing the need for further studies to improve its safety and effectiveness as a treatment option.]
Read the full abstract

Top posts

Most liked on X and Bluesky
EAPCCT
@eapcct · X

Cucurbitacins also exhibit potent anti-inflammatory, antioxidant, antiviral, hypoglycemic, hepatoprotective, neuroprotective, and anti-cancer activities via the regulation of various signaling pathways. https://t.co/M1v1kA0cxM

Mar 23, 2023 · 3 likes · 1,754 followers View post →

All mentions

EAPCCT
@eapcct · X

Cucurbitacins also exhibit potent anti-inflammatory, antioxidant, antiviral, hypoglycemic, hepatoprotective, neuroprotective, and anti-cancer activities via the regulation of various signaling pathways. https://t.co/M1v1kA0cxM

Mar 23, 2023 · 3 likes · 1,754 followers View post →